Organogenesis Inc. is set to acquire Nutech Medical Inc. a private company and supplier of tissue products used in spinal and orthopedic surgeries. Financial details surrounding the deal were not disclosed.
Like their biopharmaceutical colleagues, publicly listed medical technology companies have roared out of the gate this year as investors flood back into health care. Companies have benefited from record-breaking market highs being driven by a increased optimism that the U.S. economy is poised to enjoy better times ahead.
The number of medical device deals and their disclosed values appear to be rising, according to data from Cortellis Deals Intelligence (CDI). CDI reported 202 med-tech deals in 2014, compared with 237 deals in 2015 and 287 deals in 2016. The total value of deals was $22.85 million in 2014, $251.06 million in 2015 and $1.54 billion in 2016.